Deutsche Bank Ag\ Maxcyte, Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in Maxcyte, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 98,436 shares of MXCT stock, worth $348,463. This represents 0.0% of its overall portfolio holdings.

Number of Shares

98,436

Previous 59,654 65.01%

Holding current value

$348,463

Previous $232,000 76.29%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$3.23 - $4.43 $125,265 - $171,804	38,782 Added 65.01%	98,436 $409,000
Q3 2024 Nov 13, 2024	BUY	$3.68 - $5.06 $63,789 - $87,710	17,334 Added 40.96%	59,654 $232,000
Q2 2024 Aug 14, 2024	BUY	$3.63 - $5.0 $20,640 - $28,430	5,686 Added 15.52%	42,320 $165,000
Q1 2024 May 15, 2024	BUY	$3.94 - $5.38 $3,798 - $5,186	964 Added 2.7%	36,634 $153,000
Q4 2023 Feb 14, 2024	SELL	$2.6 - $5.24 $4,222 - $8,509	-1,624 Reduced 4.35%	35,670 $167,000
Q3 2023 Nov 09, 2023	BUY	$3.02 - $5.1 $20,883 - $35,266	6,915 Added 22.76%	37,294 $116,000
Q2 2023 Aug 14, 2023	SELL	$3.69 - $5.35 $86,604 - $125,564	-23,470 Reduced 43.58%	30,379 $139,000
Q1 2023 May 15, 2023	BUY	$4.03 - $5.89 $72,306 - $105,678	17,942 Added 49.97%	53,849 $266,000
Q4 2022 Feb 13, 2023	BUY	$4.92 - $7.4 $2,858 - $4,299	581 Added 1.64%	35,907 $196,000
Q3 2022 Nov 14, 2022	SELL	$4.52 - $6.51 $26,270 - $37,836	-5,812 Reduced 14.13%	35,326 $230,000
Q2 2022 Aug 11, 2022	SELL	$3.59 - $6.81 $46,020 - $87,297	-12,819 Reduced 23.76%	41,138 $195,000
Q1 2022 May 13, 2022	SELL	$5.26 - $10.84 $32,633 - $67,251	-6,204 Reduced 10.31%	53,957 $377,000
Q4 2021 Feb 11, 2022	BUY	$8.87 - $12.94 $453,700 - $661,881	51,150 Added 567.64%	60,161 $613,000
Q3 2021 Nov 04, 2021	BUY	$12.21 - $17.2 $110,024 - $154,989	9,011 New	9,011 $110,000

Others Institutions Holding MXCT

# of Institutions

123

Shares Held

69.8M

Call Options Held

8.7K

Put Options Held

View Full List

About MAXCYTE, INC.

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $360M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

More about MXCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account